Literature DB >> 10886784

CD135 (Flk2/Flt3) expression by human thymocytes delineates a possible role of FLT3-ligand in T-cell precursor proliferation and differentiation.

J M Bertho1, A Chapel, S Loilleux, J Frick, J Aigueperse, N C Gorin, P Gourmelon.   

Abstract

The expression of the Flk2/Flt3 molecule (CD135), the receptor for Flt3 ligand (FL), was investigated in the human thymus. Results showed that there is a high level of expression of CD135 by thymocyte populations, especially by intrathymic T-cell precursor populations. As these results suggested a role for FL in the regulation of thymic T-cell precursor differentiation and/or proliferation, we used an in vitro model of thymic stromal cell cultures in order to delineate the activity of FL on human CD7(high)CD3-CD4-CD8- triple negative intrathymic T-cell precursors. Results showed that FL, either alone or in combination with stem cell factor (SCF) induced the proliferation of CD7(high) precursors, but to a lower extent than interleukin-7 (IL-7) or IL-7 + SCF, used as positive controls. In the presence of FL + SCF, CD7(high) cells developed mainly towards a CD11b+ phenotype whereas IL-7 + SCF preferentially induce a CD3+TcRgammadelta+CD8+ phenotype. Taken together, these data suggest that FL may play a role in inducing the proliferation of CD7(high) human intrathymic T-cell precursors, but also in the induction of a myeloid differentiation pathway within the human thymus.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10886784     DOI: 10.1046/j.1365-3083.2000.00746.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  3 in total

Review 1.  Strategies for reconstituting and boosting T cell-based immunity following haematopoietic stem cell transplantation: pre-clinical and clinical approaches.

Authors:  Ann P Chidgey; Natalie Seach; Jarrod Dudakov; Maree V Hammett; Richard L Boyd
Journal:  Semin Immunopathol       Date:  2008-11-04       Impact factor: 9.623

2.  Efficacy and safety of CDX-301, recombinant human Flt3L, at expanding dendritic cells and hematopoietic stem cells in healthy human volunteers.

Authors:  N Anandasabapathy; G Breton; A Hurley; M Caskey; C Trumpfheller; P Sarma; J Pring; M Pack; N Buckley; I Matei; D Lyden; J Green; T Hawthorne; H C Marsh; M Yellin; T Davis; T Keler; S J Schlesinger
Journal:  Bone Marrow Transplant       Date:  2015-04-27       Impact factor: 5.483

3.  CDX-301: a novel medical countermeasure for hematopoietic acute radiation syndrome in mice.

Authors:  Merriline Satyamitra; Lynnette Cary; Dylan Dunn; Gregory P Holmes-Hampton; Lawrence J Thomas; Sanchita P Ghosh
Journal:  Sci Rep       Date:  2020-02-04       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.